Article
Molecular Diagnosis for Personalized Target Therapy in Gastric Cancer
1 Jan 2013
Abstract excerpt
Gastric cancer is the second leading cause of cancer-related deaths worldwide. In advanced and metastatic gastric cancer, the conventional chemotherapy with limited efficacy shows an overall survival period of about 10 months. Patient specific and effective treatments known as personalized cancer therapy is of significant importance. Advances in high-throughput technologies such as microarray and next generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
